SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-099991
Filing Date
2017-03-28
Accepted
2017-03-28 17:21:04
Documents
4
Period of Report
2017-05-08
Effectiveness Date
2017-03-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d535121ddef14a.htm DEF 14A 296405
2 GRAPHIC g535121001.jpg GRAPHIC 119935
3 GRAPHIC g535121002.jpg GRAPHIC 126770
4 GRAPHIC g535121g49w26.jpg GRAPHIC 24711
  Complete submission text file 0001193125-17-099991.txt   671725
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36327 | Film No.: 17719893
SIC: 2834 Pharmaceutical Preparations